[Lyme disease in Iceland - Epidemiology from 2011 to 2015].


Journal

Laeknabladid
ISSN: 0023-7213
Titre abrégé: Laeknabladid
Pays: Iceland
ID NLM: 7901326

Informations de publication

Date de publication:
Feb 2019
Historique:
entrez: 5 2 2019
pubmed: 5 2 2019
medline: 18 12 2019
Statut: ppublish

Résumé

Lyme disease is caused by an infection with Borrelia burgdorferi sensu latu (B. burgdorferi sl.) which is carried by Ixodes ticks. The disease has not been considered to be endemic in Iceland and no cases of Icelandic origin have been published. The epidemiology of Lyme disease in Iceland has never been studied. The objective of this study was to provide basic epidemiological information about Lyme disease in Iceland. Included in the study were all pa--tients who had a measurement of serum antibodies against B. burgdorferi sl. or were diagnosed with Lyme disease (ICD-10, A69.2) at Landspítali University Hospital in Iceland from 2011-2015. Clinical data regarding these patients was retrospectively collected from medical records and the database of the Department of clinical microbiology at Landspítali University Hospital. 501 patient had a measurement of serum antibodies against B. burgdorferi sl. and 11 patients were clinically diag-nosed with Lyme disease during the study period. 33 patients fulfilled criteria for a confirmed diagnosis of Lyme disease. 32 (97%) patients had erythema migrans and one (3%) patient had neuroborreliosis. An average of 6.6 cases were diagnosed a year (two cases per 100,000 persons/year). All cases originated abroad. Lyme disease is rare in Iceland. On average around 6 to 7 cases are diagnosed every year, primarily localised infec-tions presenting as erythema migrans. None of the cases had a definitive Icelandic origin and the yearly number of cases has not been increasing.

Identifiants

pubmed: 30713153
doi: 10.17992/lbl.2019.02.215
doi:

Types de publication

Journal Article

Langues

ice

Sous-ensembles de citation

IM

Pagination

63-70

Auteurs

Hannes Bjarki Vigfusson (HB)

Department of clinical microbiology, Landspítali University Hospital.

Hordur Snaevar Hardarson (HS)

Department of clinical microbiology, Landspítali University Hospital, Department of paediatrics, Landspítali University Hospital.

Bjorn Runar Ludviksson (BR)

Department of immunology, Landspítali University Hospital, Faculty of medicine, University of Iceland.

Olafur Gudlaugsson (O)

Department of infectious diseases, Landspítali University Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH